Dysregulation of intracellular dopamine stores revealed in the R6/2 mouse striatum.

PubWeight™: 1.10‹?› | Rank: Top 10%

🔗 View Article (PMC 3999965)

Published in J Neurochem on November 19, 2009

Authors

Andrea N Ortiz1, Benjamin J Kurth, Gregory L Osterhaus, Michael A Johnson

Author Affiliations

1: Department of Chemistry and R. N. Adams Institute for Bioanalytical Chemistry, The University of Kansas, Lawrence, Kansas 66047-7572, USA.

Articles citing this

Dopamine release in the basal ganglia. Neuroscience (2011) 1.67

Differential electrophysiological changes in striatal output neurons in Huntington's disease. J Neurosci (2011) 1.27

Cholesterol metabolism in Huntington disease. Nat Rev Neurol (2011) 1.14

The importance of integrating basic and clinical research toward the development of new therapies for Huntington disease. J Clin Invest (2011) 1.11

Dopamine imbalance in Huntington's disease: a mechanism for the lack of behavioral flexibility. Front Neurosci (2013) 0.99

Allosteric activation of M4 muscarinic receptors improve behavioral and physiological alterations in early symptomatic YAC128 mice. Proc Natl Acad Sci U S A (2015) 0.93

Disease-toxicant interactions in manganese exposed Huntington disease mice: early changes in striatal neuron morphology and dopamine metabolism. PLoS One (2012) 0.92

Corticostriatal circuit dysfunction in Huntington's disease: intersection of glutamate, dopamine and calcium. Future Neurol (2010) 0.89

Terminal effects of optogenetic stimulation on dopamine dynamics in rat striatum. J Neurosci Methods (2013) 0.89

The role of dopamine in Huntington's disease. Prog Brain Res (2014) 0.89

In vivo Dopamine Efflux is Decreased in Striatum of both Fragment (R6/2) and Full-Length (YAC128) Transgenic Mouse Models of Huntington's Disease. Front Syst Neurosci (2011) 0.88

Altered dopamine and serotonin metabolism in motorically asymptomatic R6/2 mice. PLoS One (2011) 0.86

Impaired dopamine release and uptake in R6/1 Huntington's disease model mice. Neurosci Lett (2011) 0.85

Dopamine Release and Uptake Impairments and Behavioral Alterations Observed in Mice that Model Fragile X Mental Retardation Syndrome. ACS Chem Neurosci (2010) 0.82

The Addenbrooke's Cognitive Examination-Revised accurately detects cognitive decline in Huntington's disease. J Neurol (2013) 0.81

Drug-primed reinstatement of cocaine seeking in mice: increased excitability of medium-sized spiny neurons in the nucleus accumbens. ASN Neuro (2013) 0.81

Motor function and dopamine release measurements in transgenic Huntington's disease model rats. Brain Res (2012) 0.80

Quantification of reserve pool dopamine in methionine sulfoxide reductase A null mice. Neuroscience (2011) 0.77

LC-MS/MS quantification of salvinorin A from biological fluids. Anal Methods (2013) 0.77

Localized drug application and sub-second voltammetric dopamine release measurements in a brain slice perfusion device. Anal Chem (2014) 0.76

Corticostriatal Dysfunction in Huntington's Disease: The Basics. Front Hum Neurosci (2016) 0.75

Impaired Brain Dopamine and Serotonin Release and Uptake in Wistar Rats Following Treatment with Carboplatin. ACS Chem Neurosci (2016) 0.75

Measurement of Total Antioxidant Capacity in Sub-μL Blood Samples Using Craft Paper-based Analytical Devices. RSC Adv (2015) 0.75

Articles cited by this

Short-term synaptic plasticity. Annu Rev Physiol (2002) 16.67

Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J Neurosci (1999) 4.56

Synaptic vesicle pools. Nat Rev Neurosci (2005) 4.36

Firing modes of midbrain dopamine cells in the freely moving rat. Neuroscience (2002) 3.22

Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. J Neurosci (1995) 2.74

Two endocytic recycling routes selectively fill two vesicle pools in frog motor nerve terminals. Neuron (2000) 2.73

Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J Neurosci (1998) 2.72

Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture. Hum Mol Genet (1998) 2.39

The reduced release probability of releasable vesicles during recovery from short-term synaptic depression. Neuron (1999) 2.20

Visualizing recycling synaptic vesicles in hippocampal neurons by FM 1-43 photoconversion. Proc Natl Acad Sci U S A (2001) 2.14

Cocaine increases dopamine release by mobilization of a synapsin-dependent reserve pool. J Neurosci (2006) 1.88

Two modes of vesicle recycling in the rat calyx of Held. J Neurosci (2003) 1.85

Synaptic vesicle pools at the frog neuromuscular junction. Neuron (2003) 1.71

Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model. J Pharmacol Exp Ther (1979) 1.65

The kinetics of exocytosis and endocytosis in the synaptic terminal of goldfish retinal bipolar cells. J Physiol (1999) 1.62

Glutamate-dependent inhibition of dopamine release in striatum is mediated by a new diffusible messenger, H2O2. J Neurosci (2003) 1.33

Dopamine release is severely compromised in the R6/2 mouse model of Huntington's disease. J Neurochem (2006) 1.29

Evidence for carrier-mediated efflux of dopamine from corpus striatum. Biochem Pharmacol (1982) 1.14

Cellular localization and development of neuronal intranuclear inclusions in striatal and cortical neurons in R6/2 transgenic mice. J Comp Neurol (2002) 1.14

The role of dopamine in motor symptoms in the R6/2 transgenic mouse model of Huntington's disease. J Neurochem (2002) 1.13

Abnormal association of mutant huntingtin with synaptic vesicles inhibits glutamate release. Hum Mol Genet (2003) 1.11

Striatal neuronal activity and responsiveness to dopamine and glutamate after selective blockade of D1 and D2 dopamine receptors in freely moving rats. J Neurosci (1999) 1.11

Glutamate regulates the spontaneous and evoked release of dopamine in the rat striatum. Neuroscience (2001) 1.07

Evidence for dysfunction of the nigrostriatal pathway in the R6/1 line of transgenic Huntington's disease mice. Neurobiol Dis (2002) 1.06

Phasic dopamine signaling during behavior, reward, and disease states. CNS Neurol Disord Drug Targets (2006) 1.03

Abnormalities in the synaptic vesicle fusion machinery in Huntington's disease. Brain Res Bull (2001) 1.00

In vivo dopamine release and uptake impairments in rats treated with 3-nitropropionic acid. Neuroscience (2009) 0.98

Two synaptic vesicle pools, vesicle recruitment and replenishment of pools at the Drosophila neuromuscular junction. J Neurocytol (2004) 0.97

Dopamine release from pharmacologically distinct storage pools in rat striatum following stimulation at frequency of neuronal bursting. Brain Res (2000) 0.95

D-amphetamine-induced release of "newly synthesized" and "stored" dopamine from the caudate nucleus in vivo. J Pharmacol Exp Ther (1975) 0.94

Catecholamine exocytosis is diminished in R6/2 Huntington's disease model mice. J Neurochem (2007) 0.90

Expression of mutant huntingtin blocks exocytosis in PC12 cells by depletion of complexin II. J Biol Chem (2003) 0.89

Rapid aggregate formation of the huntingtin N-terminal fragment carrying an expanded polyglutamine tract. Biochem Biophys Res Commun (1999) 0.88

Amphetamine releases dopamine from synaptic vesicles by dual mechanisms. Neurosci Lett (1996) 0.88

The effect of psychostimulants on [3H]dopamine uptake and release in rat brain synaptic vesicles. J Neural Transm (Vienna) (2005) 0.88

Complex response to afferent excitatory bursts by nucleus accumbens medium spiny projection neurons. J Neurophysiol (2004) 0.86

Binding of 125I-iodovinyltetrabenazine to CNS vesicular monoamine transport sites. Synapse (1994) 0.86

Contribution of vesicular and cytosolic dopamine to the increased striatal dopamine efflux elicited by intrastriatal injection of dexamphetamine. Neuroscience (2005) 0.78

Articles by these authors

Resolving neurotransmitters detected by fast-scan cyclic voltammetry. Anal Chem (2004) 3.18

Reduced sensitivity of influenza A (H5N1) to oseltamivir. Emerg Infect Dis (2007) 1.81

Characterization of a protective monoclonal antibody recognizing Staphylococcus aureus MSCRAMM protein clumping factor A. Infect Immun (2003) 1.67

S-nitrosothiol depletion in amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A (2006) 1.11

In-vivo electrochemistry: what can we learn about living systems? Chem Rev (2008) 1.11

DOTA-D-Tyr(1)-octreotate: a somatostatin analogue for labeling with metal and halogen radionuclides for cancer imaging and therapy. Bioconjug Chem (2002) 1.07

Force-plate quantification of progressive behavioral deficits in the R6/2 mouse model of Huntington's disease. Behav Brain Res (2009) 0.99

Biological activity of the tryprostatins and their diastereomers on human carcinoma cell lines. J Med Chem (2002) 0.98

Household light makes global heat: high black carbon emissions from kerosene wick lamps. Environ Sci Technol (2012) 0.97

A low-cost particle counter as a realtime fine-particle mass monitor. Environ Sci Process Impacts (2012) 0.90

Porcine adenovirus as a delivery system for swine vaccines and immunotherapeutics. Vet J (2005) 0.87

Dysregulation of coordinated neuronal firing patterns in striatum of freely behaving transgenic rats that model Huntington's disease. Neurobiol Dis (2009) 0.85

Impaired dopamine release and uptake in R6/1 Huntington's disease model mice. Neurosci Lett (2011) 0.85

Dopamine D(2) receptor function is compromised in the brain of the methionine sulfoxide reductase A knockout mouse. J Neurochem (2010) 0.84

Measuring forelimb force control and movement in Fischer 344/Brown Norway rats: effects of age and lorazepam. Behav Pharmacol (2006) 0.83

Dopamine Release and Uptake Impairments and Behavioral Alterations Observed in Mice that Model Fragile X Mental Retardation Syndrome. ACS Chem Neurosci (2010) 0.82

Novel animal pole-enriched maternal mRNAs are preferentially expressed in neural ectoderm. Dev Dyn (2013) 0.82

Protection of pigs against 'in contact' challenge with classical swine fever following oral or subcutaneous vaccination with a recombinant porcine adenovirus. Virus Res (2003) 0.81

Inspiratory muscle training abolishes the blood lactate increase associated with volitional hyperpnoea superimposed on exercise and accelerates lactate and oxygen uptake kinetics at the onset of exercise. Eur J Appl Physiol (2011) 0.81

Motor function and dopamine release measurements in transgenic Huntington's disease model rats. Brain Res (2012) 0.80

Loading of trained inspiratory muscles speeds lactate recovery kinetics. Med Sci Sports Exerc (2010) 0.80

Nanoscale surface tracking of laser material processing using phase shifting diffraction interferometry. Opt Express (2014) 0.79

Synthesis and structure-activity relationship studies on tryprostatin A, an inhibitor of breast cancer resistance protein. Bioorg Med Chem (2008) 0.79

Caloric restriction alleviates abnormal locomotor activity and dopamine levels in the brain of the methionine sulfoxide reductase A knockout mouse. Neurosci Lett (2009) 0.79

The effects of inspiratory muscle training on plasma interleukin-6 concentration during cycling exercise and a volitional mimic of the exercise hyperpnea. J Appl Physiol (1985) (2013) 0.78

The effects of inspiratory muscle training in older adults. Med Sci Sports Exerc (2015) 0.77

Sequence and function of canine herpesvirus alpha-transinducing factor and its interaction with an immediate early promoter. Virus Genes (2006) 0.77

Antibody fragments, expressed by a fowl adenovirus vector, are able to neutralize infectious bursal disease virus. Avian Pathol (2010) 0.76

Inspiratory muscle training reduces blood lactate concentration during volitional hyperpnoea. Eur J Appl Physiol (2008) 0.76

Localized drug application and sub-second voltammetric dopamine release measurements in a brain slice perfusion device. Anal Chem (2014) 0.76

Impaired Brain Dopamine and Serotonin Release and Uptake in Wistar Rats Following Treatment with Carboplatin. ACS Chem Neurosci (2016) 0.75

Simultaneous measurement and quantitation of 4-hydroxyphenylacetic acid and dopamine with fast-scan cyclic voltammetry. Analyst (2015) 0.75

Response. Med Sci Sports Exerc (2013) 0.75

Conference Report: Pittcon 2013: microfluidics, electrochemistry, and much much more. Bioanalysis (2013) 0.75

Effect of taurine on regulation of GABA and acetylcholine biosynthesis. Adv Exp Med Biol (2003) 0.75

High ratio plasma resuscitation does not improve survival in pediatric trauma patients. J Trauma Acute Care Surg (2017) 0.75

A Prebiotic Galactooligosaccharide Mixture (B-GOS) Reduces Severity of Hyperpnea-Induced Bronchoconstriction and Airway Inflammation: 1647 Board #300 June 2, 9: 00 AM - 10: 30 AM. Med Sci Sports Exerc (2016) 0.75

Rate and Reasons for Repeat CT Scanning in Transferred Trauma Patients. Am Surg (2017) 0.75

The Nocebo Effects Of Moderate Hypoxia On Cycling Performance And Locomotor Muscle Fatigue: 2552 Board #75 June 3, 9: 30 AM - 11: 00 AM. Med Sci Sports Exerc (2016) 0.75

Change of self-focusing behavior of phosphate glass resulting from exposure to ultraviolet nanosecond laser pulses. Opt Express (2013) 0.75

Influence of oxidative stress, diaphragm fatigue, and inspiratory muscle training on the plasma cytokine response to maximum sustainable voluntary ventilation. J Appl Physiol (1985) (2014) 0.75

In vivo electrochemical measurements: past, present and future. Bioanalysis (2013) 0.75